Stay updated with breaking news from Zusz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- Company to further expand its DECODE™ discovery platform, accelerate multiple oncology clinical programs, and advance discovery programs in oncology, autoimmune disorders, infectious disease, and other serious diseasesCAMBRIDGE, Mass.--(BUSINESS WIRE)--Repertoire Immune Medicines, a clinical-stage biotech company...
But Zurich Middle East CEO remains ‘committed’ to a ‘multi-channel distribution strategy’
Pictet Asset Services expands in Monaco Pictet Asset Services, the asset servicing business line of the Pictet Group, is opening a booking centre for external asset managers in Monaco in April 2021, with a local presence of dedicated client relationship managers. Marc Briol, chief executive of Pictet Asset Services, said: "We are pleased to develop our activity in Monaco, in line with the Pictet Group's commitment to the European market. This expansion represents an opportunity to develop long term relationships with investment fund managers based in the principality seeking high quality serv...
Swiss watch expo switches to Shanghai after virtual debut Issued on: 13/04/2021 - 04:22 In previous years the salon has been a fixture of Geneva's international calendar OLIVIER VOGELSANG AFP 4 min Zurich (AFP) Geneva's international expo of fine watches switches to Shanghai on Wednesday for a physical version after staging an online edition to keep the prestigious fair going during the pandemic. The Salon International de la Haute Horlogerie, now restyled as Watches and Wonders, was cancelled last year due to the coronavirus crisis. This year, wit...
* Lonza also makes ingredients for ex-U.S. supplies * Rovi CEO: Deal a 'significant growth opportunity' MADRID, April 12 (Reuters) - Contract drugmaker Rovi is to make active ingredients for Moderna's COVID-19 vaccine, extending an existing agreement to bottle the vaccine using ingredients brought in from Switzerland. Madrid-based Rovi, whose shares rose 4% on Monday towards a record high set last month, will build capacity to supply active agents for up to 100 million vaccine doses annually for Moderna from its plant in the southern city of Granada via a new production line. Another Rovi pla...